搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
14 小时
on MSN
Researchers discover short form of a tumor-produced protein activates natural killer cells
A group of scientists in China has revealed a novel mechanism whereby a short form of IL-18, generated by caspase-3 cleavage ...
eLife
3 天
Drug combination prediction for cancer treatment using disease-specific drug response ...
retriever generates disease-specific transcriptional drug response signatures by merging transcriptional signatures over time, concentration, and cell-type. These signatures can then be matched to ...
Interesting Engineering
13 天
Scientists create tiny anticancer weapons that make tumors destroy themselves
Researchers at the University of Pennsylvania have introduced lab-engineered small extracellular vesicles to target tumors in ...
news.ucsb.edu
7 天
‘Brave and bold’ new strategies for cancer immunotherapy
Professor Meghan Morrissey earns an innovation award to program immune cells to attack cancer tumors. #immunotherapy ...
openaccessgovernment
3 天
Personalized medicine in oncology: Small molecule inhibitors, biologics and immunotherapies
Priya Hays, Hays Documentation Specialists, discusses innovations and advancements in the development of personalized cancer ...
GEN
3 天
Cancer Immunotherapy: From Nineteenth-Century Beginnings to Modern Breakthroughs
Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...
STAT
6 天
CAR-T cells can arm other immune cells with engineered proteins to fight cancer, study says
Researchers found that bioengineered CAR-T cells when mixed with other immune cells can "donate" proteins, suggesting ...
labiotech
2 天
World Cancer Day: trends in cancer therapeutics to look forward to in 2025
As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...
New Atlas
10 天
Breast cancer cure rates almost doubled in combo therapy trial
A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈